The Parietal Cell Antibody (ACPA) test is used to detect the presence of antibodies against the parietal cells in the stomach lining. Parietal cells produce hydrochloric acid and intrinsic factor, which are essential for digestion and the absorption of vitamin B12.
Parietal Cell Antibodies (ACPA): These are autoantibodies that target the parietal cells in the stomach. Their presence can indicate autoimmune gastritis, a condition where the immune system attacks the stomach lining, leading to inflammation and potential damage.
Intrinsic Factor: Parietal cells also produce intrinsic factor, which is necessary for vitamin B12 absorption. Damage to parietal cells can lead to vitamin B12 deficiency, potentially resulting in pernicious anemia.
Diagnose autoimmune gastritis: The presence of ACPA is a marker of autoimmune gastritis, a condition that can lead to chronic inflammation of the stomach lining and reduce the stomach's ability to produce acid and absorb vitamin B12.
Screen for pernicious anemia: Autoimmune gastritis is a common cause of pernicious anemia, which occurs due to vitamin B12 deficiency. The test helps identify individuals at risk of developing this condition.
Monitor existing autoimmune conditions: The test may be used in individuals who already have autoimmune conditions to assess the potential development of autoimmune gastritis or related complications.